Filing Details

Accession Number:
0001181431-11-008489
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-09 12:00:00
Reporting Period:
2011-02-07
Filing Date:
2011-02-09
Accepted Time:
2011-02-09 13:22:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1355818 L Judy Brown C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-07 6,061 $35.85 26,194 No 4 M Direct
Common Stock Acquisiton 2011-02-07 3,600 $14.69 29,794 No 4 M Direct
Common Stock Acquisiton 2011-02-07 5,358 $20.50 31,152 No 4 M Direct
Common Stock Acquisiton 2011-02-07 6,959 $30.06 42,111 No 4 M Direct
Common Stock Disposition 2011-02-07 21,978 $71.38 20,133 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2011-02-07 6,061 $0.00 6,061 $35.85
Common Stock Employee Stock Option Right to Buy Disposition 2011-02-07 3,600 $0.00 3,600 $14.69
Common Stock Employee Stock Option Right to Buy Disposition 2011-02-07 5,358 $0.00 5,358 $20.50
Common Stock Employee Stock Option Right to Buy Disposition 2011-02-07 6,959 $0.00 6,959 $30.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-08-25 2018-08-25 No 4 M Direct
0 2010-09-14 2015-09-14 No 4 M Direct
0 2010-08-30 2017-08-30 No 4 M Direct
0 2010-08-25 2019-08-25 No 4 M Direct
Footnotes
  1. The price in column 4 is a weighted average. The prices actually ranged from $71.27 to $71.55. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each seperate price within the range.